281 related articles for article (PubMed ID: 17336562)
21. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
[TBL] [Abstract][Full Text] [Related]
22. Apparent allelism of the Hurler, Scheie, and Hurler/Scheie syndromes.
Mueller OT; Shows TB; Opitz JM
Am J Med Genet; 1984 Jul; 18(3):547-56. PubMed ID: 6433708
[TBL] [Abstract][Full Text] [Related]
23. [Mucopolysaccharidosis IS: Scheie's syndrome. A report of 2 brothers].
Bonora G; Frattini D; Nedbal M; Massironi C; Perletti L
Pediatr Med Chir; 1991; 13(6):631-6. PubMed ID: 1839643
[TBL] [Abstract][Full Text] [Related]
24. Arthropathy-like findings and a carpal tunnel syndrome as the presenting features of Scheie syndrome: Three cases from the same family.
Gökay S; Kardaş F; Kendirci M; Sözeri B
Turk J Pediatr; 2018; 60(3):344-347. PubMed ID: 30511553
[TBL] [Abstract][Full Text] [Related]
25. Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome.
Bijarnia S; Shaw P; Vimpani A; Smith R; Pacey V; O'Grady H; Christodoulou J; Sillence D
J Paediatr Child Health; 2009; 45(7-8):469-72. PubMed ID: 19712183
[TBL] [Abstract][Full Text] [Related]
26. Hurler-Scheie syndrome in Niger: a case series.
Assadeck H; Toudou Daouda M; Bako H; Hassane Djibo F
J Med Case Rep; 2019 Apr; 13(1):102. PubMed ID: 31018863
[TBL] [Abstract][Full Text] [Related]
27. [Mucopolysaccharidosis type I, Hurler-Scheie phenotype with ocular involvement. Clinical and ultrastructural study].
Girard B; Hoang-Xuan T; D'Hermies F; Savoldelli M; Bennouna M; Poenaru L; Maroteaux P; Pouliquen Y
J Fr Ophtalmol; 1994; 17(4):286-95. PubMed ID: 8089412
[TBL] [Abstract][Full Text] [Related]
28. Growth patterns for untreated individuals with MPS I: Report from the international MPS I registry.
Viskochil D; Clarke LA; Bay L; Keenan H; Muenzer J; Guffon N
Am J Med Genet A; 2019 Dec; 179(12):2425-2432. PubMed ID: 31639289
[TBL] [Abstract][Full Text] [Related]
29. Laronidase treatment of mucopolysaccharidosis I.
Wraith EJ; Hopwood JJ; Fuller M; Meikle PJ; Brooks DA
BioDrugs; 2005; 19(1):1-7. PubMed ID: 15691212
[TBL] [Abstract][Full Text] [Related]
30. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.
Cox-Brinkman J; Boelens JJ; Wraith JE; O'meara A; Veys P; Wijburg FA; Wulffraat N; Wynn RF
Bone Marrow Transplant; 2006 Jul; 38(1):17-21. PubMed ID: 16715104
[TBL] [Abstract][Full Text] [Related]
31. Ocular findings in four children with mucopolysaccharidosis I-Hurler (MPS I-H) treated early with haematopoietic stem cell transplantation.
Fahnehjelm KT; Törnquist AL; Malm G; Winiarski J
Acta Ophthalmol Scand; 2006 Dec; 84(6):781-5. PubMed ID: 17083538
[TBL] [Abstract][Full Text] [Related]
32. [The development of cognitive functions in children with Hurler phenotype mucopolysaccharidosis type I on enzyme replacement therapy with laronidase].
Biernacka M; Jakubowska-Winecka A; Tylki-Szymańska A
Pediatr Endocrinol Diabetes Metab; 2010; 16(4):249-54. PubMed ID: 21447265
[TBL] [Abstract][Full Text] [Related]
33. Mucopolysaccharidosis type-IS presenting with onset of carpal tunnel syndrome at adolescence.
Bahadir C; Kurtulus D; Cihandide E
J Clin Rheumatol; 2009 Dec; 15(8):402-4. PubMed ID: 19955999
[TBL] [Abstract][Full Text] [Related]
34. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
[TBL] [Abstract][Full Text] [Related]
35. Young-onset dementia: demographic and etiologic characteristics of 235 patients.
Kelley BJ; Boeve BF; Josephs KA
Arch Neurol; 2008 Nov; 65(11):1502-8. PubMed ID: 19001170
[TBL] [Abstract][Full Text] [Related]
36. Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening.
de Ru MH; Bouwman MG; Wijburg FA; van Zwieten MC
Mol Genet Metab; 2012 Nov; 107(3):501-7. PubMed ID: 22926196
[TBL] [Abstract][Full Text] [Related]
37. Mucopolysaccharidosis Type I.
Kubaski F; de Oliveira Poswar F; Michelin-Tirelli K; Matte UDS; Horovitz DD; Barth AL; Baldo G; Vairo F; Giugliani R
Diagnostics (Basel); 2020 Mar; 10(3):. PubMed ID: 32188113
[TBL] [Abstract][Full Text] [Related]
38. Mucopolysaccharidosis I: management and treatment guidelines.
Muenzer J; Wraith JE; Clarke LA;
Pediatrics; 2009 Jan; 123(1):19-29. PubMed ID: 19117856
[TBL] [Abstract][Full Text] [Related]
39. Hurler-Scheie compound-a variant of MPS-i (MPS-i H/S) (A case report).
Bhandari B; Ranka SL
Indian Pediatr; 1980 Dec; 17(12):971-3. PubMed ID: 6788695
[No Abstract] [Full Text] [Related]
40. Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis.
Ferrari S; Ponzin D; Ashworth JL; Fahnehjelm KT; Summers CG; Harmatz PR; Scarpa M
Br J Ophthalmol; 2011 May; 95(5):613-9. PubMed ID: 20852315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
